Study design of Dal-GenE, a pharmacogenetic trial targeting reduction of cardiovascular events with dalcetrapib-Reference-Cited by-同舟云学术

Study design of Dal-GenE, a pharmacogenetic trial targeting reduction of cardiovascular events with dalcetrapib

Published:2020-04 Issue: Volume:222 Page:157-165
ISSN:0002-8703
Container-title:American Heart Journal
language:en
Short-container-title:American Heart Journal

Author:

Tardif Jean-Claude,Dubé Marie-Pierre,Pfeffer Marc A.,Waters David D.,Koenig Wolfgang,Maggioni Aldo P.,McMurray John J.V.,Mooser Vincent,White Harvey D.,Heinonen Therese,Black Donald M.,Guertin Marie-Claude

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference21 articles.

1. World Health Organization. https://www.who.int/news-room/fact-sheets/detail/cardiovascular-diseases-(cvds)

2. Cardiovascular efficacy and safety of bococizumab in high-risk patients;Ridker;N Engl J Med,2017

3. Evolocumab and clinical outcomes in patients with cardiovascular disease;Sabatine;N Engl J Med,2017

4. Alirocumab and cardiovascular outcomes after acute coronary syndrome;Schwartz;N Engl J Med,2018

5. Inflammation and beyond: new directions and emerging drugs for treating atherosclerosis;Bertrand;Expert Opin Emerg Drugs,2017

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Role of CETP, PCSK-9, and CYP7-alpha in cholesterol metabolism: Potential targets for natural products in managing hypercholesterolemia;Life Sciences;2024-08

2. Pharmacogenomics in cardiovascular disease;Diagnostic Molecular Pathology;2024

3. Cardiovascular precision and personalised medicine;Genomic and Molecular Cardiovascular Medicine;2024

4. Special Patient Populations;Clinical Lipidology;2024

5. Pharmacogenetics of cardiovascular drugs;Current Opinion in Cardiology;2023-03-28